openPR Logo
Press release

Antiviral Drugs Market Research Report, Industry Trends, Share, Size, Demand

08-07-2020 05:51 PM CET | Health & Medicine

Press release from: Transparency Market Research

The vendor landscape of the antiviral drugs market is consolidated with the dominated of few players, says Transparency Market Research (TMR). Some of the prominent players operating in the antiviral drugs market are F. Hoffmann-La Roche AG, Bristol-Myers-Squibb, Johnson & Johnson, and Merck & Co. The market shares of geriatric players in increasing rapidly in the market Some of geriatric players operating in the antiviral drugs market are Aurobindo Pharma, Cipla, and Dr Reddy’s.

The players in the antiviral drugs market are focusing towards the development of generic version of key blockbuster drugs. For instance, Aurobindo Pharma received patent for Valganciclovir geriatric version. This will help the company gain greater cosunmer preference on the virtue of lower costs.

Promient players are collaborating with the geriatric players to remain competitive in the global market. For instance, in 2016, Roche announced its plans to take over anti-influenza drug molecule of a key competitor Shionogi after facing heavy generic competition from the star drug Tamiflu.

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) :https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21083

A recently released report by TMR elucidates that the anitiviral drugs market is projected to rise at a CAGR of 6.40% during the forecast period that is from 2016 and 2024. Rising at this CAGR, the antiviral drugs market is projected to clock a valuation of US$82.9 bn by 2024.

In the year 2015, North America dominated the regional segment of the antiviral drugs market with a revenue share of 30%. Factors that played vital role for the highest growth of the region is high level of drug development, presence of key players as well as well developed and sophisticated healthcare infrastructure. Based on distribution type, the online pharmacy segment is estimated to grow at a prominent pace in the near future. Factors like increasing trend of online purchasing, rising smart phone penetration, and growing digitalization are significantly contributing towards the growth of online pharmacies over the forecast period.

REQUEST FOR COVID19 IMPACT ANALYSIS –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=21083

Increasing Incidence of Chronic Diseases to Bolster Market’s Growth

The global antiviral drugs market is projected to rise at a significant pace in the coming few years. This is mainly due to the increasing prevalence of Sexually Transmitted Infections (STIs) across the globe. Further availability of strong product pipeline is another factor expected to propel the growth of the global antiviral drugs market in the coming years.

Moreover, in recent few years, there is a significant increase in epidemics of viral infections, and respiratory syncytial virus. This is mainly due to changing envorioenment conditons on account of increasing poultion level. These has resulted the development of novel therapeutics for antiviral drugs thus bolstering the market’s growth.

As per a study, over 36 million people around the globe are suffering from HIV infection in 2014. Further, the population in the region touched 2.0 million new cases of HIV. This is expected to strengthen the prospects of the antiviral drugs market in the coming few years.

Buy Now Report : https://www.transparencymarketresearch.com/checkout.php?rep_id=21083<ype=S

Stringent Governmental Regulation Regarding Sales and Manufacturing of Antiviral Drugs to Hamper Markets Growth

However, stringent governmental regulation for FDA approval of antiviral drugs and improper heath care infrastructure is projected to hamper the growth of the global antiviral drugs market. Nevertheless, increasing drug approvals for combination therapies for the effective treatment of the targeted diseases is another strong factor estimated to contribute towards the growth potential to the antiviral drugs market

The information is derived from TMR report titled, “Antiviral Drugs Market (Disease Indication – Hepatitis Virus Infection, HIV Infection, and Respiratory Virus Infection; Product Type – Branded Drugs and Generic Drugs; Distribution Channels – Hospital Pharmacy Store, Retail Pharmacy Store, and Online Pharmacy) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 – 2024.”

The global antiviral drugs market is segmented as follows:

Disease Indication

Hepatitis Virus Infection
HIV Infection
Respiratory Virus Infection
Others
Product Type

Branded Drugs
Generic Drugs
Distribution Channels

Hospital Pharmacy Store
Retail Pharmacy Store
Online Pharmacy
Geography

North America
Europe
Asia Pacific
Latin America
Middle East & Africa
More Trending Reports by Transparency Market Research – 1. https://www.prnewswire.com/news-releases/rising-complications-due-to-diabetes-is-pushing-adoption-of-diabetic-ulcers-treatment-market-valuation-will-rise-up-to-us13-6-bn-by-2026-end-finds-tmr-report-301016214.html

2. https://www.biospace.com/article/epilepsy-monitoring-devices-market-increase-in-incidence-of-head-injuries-brain-cancer-infections-and-substance-abuse-to-drive-global-market/

Contact

Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiviral Drugs Market Research Report, Industry Trends, Share, Size, Demand here

News-ID: 2107002 • Views:

More Releases from Transparency Market Research

Soy and Milk Protein Ingredients Market to Reach USD 67.0 Billion by 2036 Amid Rising Demand for High-Protein and Plant-Based Diets
Soy and Milk Protein Ingredients Market to Reach USD 67.0 Billion by 2036 Amid R …
The global Soy and Milk Protein Ingredients Market is witnessing significant momentum as consumers increasingly prioritize high-protein diets, functional nutrition, and clean-label ingredients. With the surge in plant-based alternatives, sports nutrition products, and fortified food offerings, soy and milk protein ingredients have become critical components across multiple industries including food & beverages, pharmaceuticals, animal nutrition, and personal care. The global Soy and Milk Protein Ingredients Market is projected to reach US$
Electric Vehicle Adhesives Market to Reach US$ 9.5 Bn by 2036, Expanding at 12.3% CAGR Amid EV Adoption Surge
Electric Vehicle Adhesives Market to Reach US$ 9.5 Bn by 2036, Expanding at 12.3 …
The global electric vehicle (EV) adhesives market was valued at US$ 2.7 Bn in 2025 and is projected to reach US$ 9.5 Bn by 2036, expanding at a robust CAGR of 12.3% from 2026 to 2036. The market is witnessing significant growth driven by accelerating electric vehicle adoption, increasing demand for lightweight materials, rapid battery technology advancements, and stricter emission regulations worldwide. Electric vehicle adhesives are specialized bonding solutions used in
Biostimulants Market to Reach US$ 99.5 Bn by 2036 Amid Rising Demand for Sustainable Agriculture
Biostimulants Market to Reach US$ 99.5 Bn by 2036 Amid Rising Demand for Sustain …
The global biostimulants market is entering a transformative growth phase as agriculture shifts toward sustainability, productivity, and environmental stewardship. Valued at US$ 36.3 Bn in 2025, the market is projected to reach US$ 99.5 Bn by 2036, expanding at a robust CAGR of 9.6% from 2026 to 2036. The surge in demand for sustainable agricultural solutions, coupled with growing consumer preference for organic products, is fueling widespread adoption of biostimulants
Carbon Fiber Market to Reach US$ 6.7 Bn by 2036, Driven by Surging Demand for Lightweight Materials in Automotive, Aerospace, and Wind Energy Sectors | Latest Report TMR
Carbon Fiber Market to Reach US$ 6.7 Bn by 2036, Driven by Surging Demand for Li …
The global carbon fiber market is poised for substantial expansion over the next decade, driven by the increasing adoption of lightweight, high-strength materials across automotive, aerospace, wind energy, and electric vehicle applications. According to recent industry analysis, the market was valued at US$ 3.2 Bn in 2025 and is projected to reach US$ 6.7 Bn by 2036, expanding at a CAGR of 6.8% from 2026 to 2036. Access key findings and

All 5 Releases


More Releases for Pharma

Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring